Alcohol Use Disorder Treatment Market Size

  • Report ID: 3804
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Alcohol Use Disorder Treatment Market Size

Alcohol Use Disorder Treatment Market size was over USD 742.08 million in 2024 and is projected to reach USD 1.62 billion by 2037, witnessing around 6.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of alcohol use disorder treatment is evaluated at USD 778.89 million. The rising incidence of alcohol use disorder (AUD) globally, backed by rising disposable income and evolving consumer habits is a significant driver, prompting a greater demand for effective treatments and interventions. In 2020, 1.34 billion individuals were estimated to have consumed alcohol in hazardous amounts. Drinking alcohol is linked to 49.3% of cases of cirrhosis and other liver disorders. In 2019, alcohol use disorders were a contributing factor in 2.4 million deaths out of which males made up 76.7%.  Further, growing awareness about the impact of alcohol addiction on health and society has led to increased recognition of the need for treatment, encouraging individuals to seek help.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3804
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of alcohol use disorder treatment is evaluated at USD 778.89 million.

The alcohol use disorder treatment market size was over USD 742.08 million in 2024 and is projected to reach USD 1.62 billion by 2037, witnessing around 6.2% CAGR during the forecast period i.e., between 2025-2037. Awareness among the population regarding advancement in treatment, supportive government policies, increased healthcare expenditure will drive the market growth.

North America industry is predicted to dominate majority revenue share of 46% by 2037, due to increasing demand for effective treatments in the region.

The major players in the market are Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, Kinnov Therapeutics, ADDEX THERAPEUTICS, Indivior PLC, Ethypharm, Omeros Corporation, Montisera Ltd./ FINNISH BIOINDUSTRIES FIB, Otsuka Pharmaceutical Co., Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample